Circulating vaccine-derived poliovirus type 1 confirmed in Papua New Guinea

Outbreak response to be launched to stop further spread of the virus

A child is protected from lifelong polio paralysis through OPV vaccination. © WHO
A child is protected from lifelong polio paralysis through OPV vaccination. © WHO

Following identification last month of an acute flaccid paralysis (AFP) case from which vaccine-derived poliovirus type 1 (VDPV1) had been isolated, genetic sequencing of two VDPV1s from two non-household contacts of the AFP case has now confirmed that VDPV1 is circulating and is being officially classified as a  ‘circulating’ VDPV type 1 (cVDPV1).

The National Department of Health (NDOH) of Papua New Guinea is closely working with the GPEI partners in launching a comprehensive response. Some of the immediate steps include conducting large-scale immunization campaigns and strengthening surveillance systems that help detect the virus early. These activities are also being strengthened in neighboring provinces.

The GPEI and its partners are continuing to work with regional and country counterparts and partners in supporting the Government of Papua New Guinea and local public health authorities in conducting a full field investigation, risk assessment and to support the planning, implementation and monitoring of the outbreak response.

For more information:

Contact Oliver Rosenbauer, Communications Officer, Global Polio Eradication Initiative, tel: +41 79 500 6536

Related resources


Related News

   20/05/2022
The first supplementary polio campaign in eight years puts caregivers to the test
   19/05/2022
Ananda talks about development of the nOPV2 vaccine its pathway to rollout, and field performance
   18/05/2022
18 May 2022
   11/05/2022
The support of community leaders and influencers is crucial in motivating parents and caregivers to vaccinate their children against polio
   28/04/2022
An outbreak response assessment led by WHO on 11 to 15 April 2022 concluded that poliovirus is no longer circulating in Tajikistan, and thereby recommended official closure of the outbreak that started in January 2021.